City of Hope

City of Hope is a non-profit clinical research center based in Duarte, California, founded in 1913, focused on cancer treatment and diabetes research. It provides access to expert doctors, coordinates clinical trials and treatment programs, and conducts biomedical research to improve patient outcomes. Designated by the National Cancer Institute as a comprehensive cancer center, City of Hope combines patient care with scientific discovery and education, supported by researchers, clinicians, nurses, and staff.

Harlan Levine MD

President of Health Innovation and Policy

5 past transactions

AccessHope

Series B in 2024
AccessHope is a health benefits company that connects employees diagnosed with cancer to top-tier medical expertise. It partners with National Cancer Institute-designated comprehensive cancer centers, providing virtual consultations, personalized treatment plans, and ongoing support. This service allows patients to access leading cancer care while remaining with their local healthcare providers, potentially improving outcomes.

Reimagine Care

Series A in 2022
Reimagine Care is a health‑care company that delivers technology‑enabled services to support community‑based oncology practices and health‑system oncology departments. The company supplies the personnel, processes, and a robust technology platform that enable scalable, patient‑centric, and lower‑cost cancer care across multiple sites, including home‑based treatment. Founded in 2020 and headquartered in Nashville, Tennessee, Reimagine Care partners with health‑care systems and independent oncology practices to promote value‑based care and improve access to high‑quality cancer treatment.

Cancer Treatment Centers of America

Acquisition in 2021
Cancer Treatment Centers of America (CTCA), founded in 1988 by Richard J. Stephenson, is a network of fully accredited cancer hospitals dedicated to providing comprehensive cancer care. The establishment of CTCA was inspired by Stephenson's personal experience with his mother’s battle against lung cancer, leading him to focus on a patient-centered approach called the Mother Standard. This model emphasizes the integration of traditional oncology treatments, such as surgery and chemotherapy, with alternative therapies aimed at enhancing the quality of life for patients. CTCA’s services include genomic tumor assessments, immunotherapy, nutrition, and various supportive therapies, such as aromatherapy and acupuncture, tailored to individual patient needs. The organization operates multiple hospitals across the United States, recognized for their high standards of care and safety, and has received numerous accreditations from respected healthcare organizations. Additionally, CTCA is committed to advancing cancer research through its Gateway for Cancer Research foundation, supporting clinical trials globally. The centers strive to empower patients and their families, ensuring they have access to a broad spectrum of treatment options and resources.

Pacific Shores Medical Group

Acquisition in 2021
Pacific Shores Medical Group is a cancer research and treatment organization located in Los Angeles and Orange counties. The company specializes in providing advanced medical care for patients diagnosed with various types of cancer and blood disorders. Its services include bone marrow transplants, infusion therapy, PET and CT scans, and telehealth consultations. Additionally, Pacific Shores Medical Group is committed to innovation in cancer treatment by offering access to the latest clinical trials for emerging therapies.

Luminat

Series A in 2014
Lumināt is a hospital and healthcare company that offers a comprehensive solution that allows provider organizations to enhance the effectiveness of advance care planning and enactment to improve the individual's and family's experience and as a result, lower the costs of care. It was founded in 2012 and headquartered in Saint Louis Park, Minnesota.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.